BioSpace News Archive

Business

Portola Pharmaceuticals to Announce Third Quarter 2017 Financial Results and Host Conference Call on Monday, November 6

The company will host a webcast and conference call to discuss the company’s financial results the same day.

October 30, 2017

·

1 min read

Business

Upsher-Smith’s Parent Company Enters Into Agreement With Astra to Manufacture And Market Migraine Medication in Japan

Upsher-Smith today reported that Sawai has entered into an exclusive agreement with Astra to manufacture and market Zomig Tablets 2.5 mg and Zomig RM Tablets 2.5 mg, a migraine medication in Japan designed to melt quickly in the mouth.

October 30, 2017

·

2 min read

Business

Daiichi Sankyo Working with Berkeley Lights’ Beacon OptoFluidic Platform for Cell Line Development

Berkeley Lights announced today a program with Daiichi Sankyo focused on using the Beacon platform to accelerate its cell line development workflow.

October 30, 2017

·

2 min read

Business

Medizone’s AsepticSure Disinfection System Introduced to Nordic Region

Medizone and Aglon a/s today announced that they have entered into an agreement for the introduction and distribution of AsepticSure in the Nordic Region.

October 30, 2017

·

3 min read

Golden Meditech Announces the Proposed Voluntary Delisting of TDR on TWSE

Golden Meditech today announces that the board of directors of the Company resolved to initiate an application for the voluntary delisting of the TDR from the TWSE, the repurchase of TDR resulting from the Voluntary Delisting and the TDR conversion offer.

October 30, 2017

·

2 min read

Drug Development

Siamab Therapeutics Presents New Preclinical Safety Data for ST1 Antibody Therapeutics Program at the 2017 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

These results add to the company’s efficacy data findings showing that its anti-STn antibody therapeutics inhibit tumor progression in cell-line-derived and patient-derived xenograft (PDX) ovarian cancer and pancreatic cancer mouse models, with complete regression observed in some treatment arms.

October 30, 2017

·

4 min read

Lone Star Bio

Apollo Endosurgery Announces Presentation of the Brazilian Intragastric Balloon Consensus Statement at ObesityWeek

This presentation reported the results of a consensus meeting held in Sao Paulo, Brazil in June 2016 of 39 endoscopists with up to 17 years of experience providing intragastric balloon therapy to patients.

October 30, 2017

·

6 min read

Drug Development

CBT Pharma Presents Data Demonstrating Anti-Tumor Activity of its PD-L1 Immunotherapy Antibody, CBT-502 at the AACR-NCI-EORTC International Conference on Molecular Target and Cancer Therapeutics

CBT Pharma presented preclinical data which showed that CBT-502 efficiently inhibited binding of PD-L1 with no binding to PD-L2, CD28, ICOS or CTLA4.

October 30, 2017

·

3 min read

Business

Theravance Biopharma to Report Third Quarter 2017 Financial Results on November 7, 2017

Theravance Biopharma today announced that it will release financial results for the period ended September 30, 2017 after market close on Tuesday, November 7, 2017.

October 30, 2017

·

3 min read

Business

McKesson Signs Agreement With NRG to Install Solar Arrays at McKesson Facility

The solar power purchase agreement represents the first step of a multi-phase plan to expand McKesson’s environmental sustainability efforts while driving cost efficiencies over the long term.

October 30, 2017

·

5 min read